A corneal ulcer is a loss of corneal epithelium with inflammation caused by bacterial or fungal infection that can lead to blindness if not treated properly. Common causes include infections from Staphylococcus or Pseudomonas bacteria. Treatment involves topical antibiotics like fortified cephazolin or tobramycin drops every few hours to control the infection along with cycloplegic drops for pain relief and prevention of complications like perforation or secondary glaucoma.
This presentation describes the background of the cornea and the corneal diseases in general, also it describes in detailed manner how to manage the corneal ulcer with its different causes
This presentation describes the background of the cornea and the corneal diseases in general, also it describes in detailed manner how to manage the corneal ulcer with its different causes
Simple eye education for EHW, Ophthalmic eye student, school eye education & first - second year optometry students only .
common eye lid inflammatory conditions .
stye or hordeolum ( external / internal hordeolum ), lid abscess , chalazion or mebomian retention cyst, accessory lacrimal glands , lacrimal gland etc...
Simple eye education for EHW, Ophthalmic eye student, school eye education & first - second year optometry students only .
common eye lid inflammatory conditions .
stye or hordeolum ( external / internal hordeolum ), lid abscess , chalazion or mebomian retention cyst, accessory lacrimal glands , lacrimal gland etc...
This slide contains information regarding corneal ulcer and glaucoma. This can be helpful for proficiency level and bachelor level nursing students. Your feedback is highly appreciated.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Welcome to Secret Tantric, London’s finest VIP Massage agency. Since we first opened our doors, we have provided the ultimate erotic massage experience to innumerable clients, each one searching for the very best sensual massage in London. We come by this reputation honestly with a dynamic team of the city’s most beautiful masseuses.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
1. DR K N Jha,MS
Professor of Ophthalmology
Email : kirtinath.jha@gmail.com
2. Learning Aim
What is corneal ulcer ?
Etiology, pathology, symptoms and signs
Differential diagnosis
Laboratory diagnosis
Treatment
Complications
3. Corneal ulcer
● Loss of corneal epithelium with inflammation
in the surrounding cornea is called corneal
ulcer.
● Corneal ulcer is one the common cause of blindness.
● It is an ocular emergency.
4. Causative Organisms
Infections are almost always exogenous
Causative organism: S.aureus, S.epidermidis, S.
pneumoniae, Pseudomonas aeruginosa,.
Uncommon: Neisseria gonorrhoeae, E. coli
Fungi : Aspergillus and Fusarium sp
5. Predisposing factors
• Trauma: e.g. Contact lenses, trichiasis, surgery
• Topical steroids
• Dry eye syndrome
• Lagophthalmos : e.g. Facial nerve palsy
• Neurotrophic keratitis resulting from viral infections and
lesions of ophthalmic division of Trigeminal nerve
• Deficiency states ( Vit. A ) and metabolic diseases ( DM)
• Poor local hygiene, and local infection ( chronic dacryocystitis)
6. Pathogenesis of Bacterial Ulcers
Bacterial adherence, proliferation, and invasion of corneal stromal lamellae
Corneal inflammation with local production of cytokines and chemokines
Diapedesis and migration of neutrophils into the peripheral cornea from
limbal vessels
Release of bacterial proteases. Enzymes released by neutrophils and activation
of matrix metallopreoteinases exacerbate inflammatory necrosis.
Healing begins with control of microbial replication.
7. Pathology of Corneal Ulcer
• Localized necrosis of the anterior layers of the cornea
• Desquamation of the epithelium and damage to the
Bowman’s membrane
• Formation of the slough and purulent infiltration
• Regeneration of the epithelium
8. Clinical Features of Corneal ulcer
Symptoms : Painful red eye, diminution of vision,
photophobia
Signs: Circumcorneal congestion, ulceration,
inflammation, and necrosis of corneal layers
9.
10. Fungal Corneal ulcer
History of trauma with vegetable matter e.g., eye
trauma during harvesting of crops.
Ulcer appears dry; it has feathery edges.
Satellite lesions may be seen.
Endothelial plaque may be visible.
Hypopyon is common.
13. Complications of Corneal Ulcer
• Descematocele
• Perforation and its complications
- Anterior synechia , Iris prolapse, expulsion of lens and
vitreous, Intraocular hemorrhage, Endophthalmitis /
panophthalmitis
• Secondary glaucoma
• Anterior capsular cataract
• Staphyloma formation
14. Assessment of Corneal ulcer
History, general, and systemic examination
- Visual acuity: may be low
- Eye and Ocular adnexa: Eye lid , lacrimal sac
Conjunctiva: circumcorneal congestion
Corneal ulcer: size, site ,surface, margin, slough, corneal
sensation, thinning , satellite lesions
Anterior chamber: Cells, flare, hypopyon
Pupil
15.
16. Microbiological Investigations
The majority are managed without smears or cultures.
Scraping from the ulcer margins and the base of the ulcer
Examination of Smear stained with Gram stain, Giemsa
stain, KOH mount for fungi
Culture on blood agar, chocolate agar, thioglycollate broth,
and Sabouraud’s dextrose agar
18. Control of Infection
Topical antibiotics
• Fortified cephazolin eye drop 50 mg / ml 1/4/6 hourly
• Fortified tobramycin eye drop 14 mg/ ml 1/4/6 hourly
Alternatives
Fortified vancomycin eye drop 25-50 mg/ml drop
Fluoroquinolone eye drop ( Cipro/ oflo/ moxifloxacin/
gatifloxacin) 0.3 % drop
Dose: 1 drop every 5-15 min for 1 hour . ½ to 1 hourly
thereafter. Reduce the dose later.
19. Antimicrobials for Fungal corneal ulcer
Topical antifungal drops:
- Natamycin 5 % 1 hourly by day and 2 hourly by night
for 6 weeks to 6 mo
- Amphotericin B 0.15/ 0.3 % frequent instillation
Oral antifungal agents; Ketoconazole 200-600 mg/ day
Fluconazole 200-400mg/ day
20. Supportive Therapy
Cycloplegics : Atropine 1 % eye drop t.i.d.
Debridement of the ulcer
Treatment of complications: perforation, secondary
glaucoma
21. Outcome of corneal ulcer
Healing with out opacity
Healing with opacity
Staphyloma
Secondary glaucoma
Cataract
Phthisis bulbi
23. Point to remember
Corneal ulcer causes painful red eye.
Trauma often is the predisposing event.
Community acquired infection often does not require
microbiological work-up.
Fluoroquinolone 0.3 % eye drop 1-2 hourly, is adequate for
small, peripheral ulcers.
Atropine ointment 1% tds relieves pain, prevents synechia.
All cases must be referred to ophthalmologist.
24. Can you recall ?
Definition of a corneal ulcer
Causative organisms
Symptoms and Signs
Microbiological investigation
Treatment of corneal ulcer
Complications of corneal ulcer
Outcome of corneal ulcer